ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 162 filers reported holding ACORDA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 2.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $193,000 | -6.3% | 67,129 | +333.2% | 0.01% | -22.2% |
| Q1 2019 | $206,000 | -80.9% | 15,495 | -77.7% | 0.01% | -57.1% |
| Q4 2018 | $1,081,000 | +398.2% | 69,415 | +816.0% | 0.02% | +162.5% |
| Q2 2018 | $217,000 | -40.1% | 7,578 | -55.1% | 0.01% | -11.1% |
| Q4 2017 | $362,000 | +39.2% | 16,886 | +36.2% | 0.01% | +12.5% |
| Q1 2017 | $260,000 | -38.2% | 12,400 | -44.6% | 0.01% | -27.3% |
| Q4 2016 | $421,000 | +22.0% | 22,400 | +65.4% | 0.01% | +57.1% |
| Q2 2016 | $345,000 | -47.0% | 13,546 | -45.0% | 0.01% | -58.8% |
| Q1 2016 | $651,000 | +37.6% | 24,615 | +73.3% | 0.02% | +13.3% |
| Q1 2015 | $473,000 | -4.6% | 14,200 | -16.5% | 0.02% | -37.5% |
| Q4 2013 | $496,000 | +88.6% | 17,000 | +120.8% | 0.02% | +118.2% |
| Q3 2013 | $263,000 | +7.8% | 7,700 | +4.1% | 0.01% | -38.9% |
| Q2 2013 | $244,000 | – | 7,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 1,546,180 | $30,460,000 | 7.00% |
| Sio Capital Management, LLC | 380,000 | $7,486,000 | 3.56% |
| SCOPIA CAPITAL MANAGEMENT LP | 7,223,906 | $142,311,000 | 2.94% |
| RA Capital Management | 900,259 | $17,735,000 | 2.04% |
| Ghost Tree Capital, LLC | 400,000 | $7,880,000 | 1.64% |
| PFM Health Sciences, LP | 2,588,157 | $50,987,000 | 1.37% |
| Partner Investment Management, L.P. | 47,752 | $941,000 | 1.26% |
| Malaga Cove Capital, LLC | 55,435 | $1,095,000 | 0.66% |
| Spark Investment Management LLC | 433,700 | $8,543,000 | 0.53% |
| Alambic Investment Management, L.P. | 217,610 | $4,287,000 | 0.52% |